← All news

TürkiyeResearch and clinical trials

Growth hormone response in 69 children with Silver-Russell syndrome: a multicenter study in Türkiye

Peer-reviewed publication

A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.

Pediatric endocrinology centers in Türkiye studied 69 children with Silver-Russell syndrome. In children who had gene testing, the most common cause was a change in the 11p15 region. Digestive and nervous system problems were common. Early puberty was also more common than in the general population. The result of growth hormone treatment was most influenced by the length of treatment.

What does it mean for patients and families?

This study shows the importance of regular growth monitoring. Few children had reached their final height, so the results are limited. Treatment decisions are made with a pediatric endocrinologist.

Source

PubMed (Journal of Pediatric Endocrinology & Metabolism): Comparison of the clinical characteristics of children with Silver-Russell syndrome genetically confirmed or not and their response to growth hormone therapy: a national multicenter study.

Scientific paper: Comparison of the clinical characteristics of children with Silver-Russell syndrome genetically confirmed or not and their response to growth hormone therapy: a national multicenter study. Journal of Pediatric Endocrinology & Metabolism, 2025. DOI: 10.1515/jpem-2024-0587 · PubMed 40440520

The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).

This page is translated from the Turkish original.

This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.